Why Shares of Anavex Life Sciences Rose 12.4% in February

The company's first-quarter earnings report detailed positive news regarding its pipeline.

Related Keywords

Christopher Missling ,Aduhelm Aducanumab ,Drug Administration ,Anavex Life Sciences ,Disease Assessment Scale Cognitive ,Excellence Phase ,